✦ LIBER ✦

Effect of host immunity on metastatic potential in renal cell carcinoma: the assessment of optimal in vivo models to study metastatic behavior of renal cancer cells

✍ Scribed by Minoru Kobayashi; Tatsuo Morita; Nicole A. L. Chun; Aya Matsui; Masafumi Takahashi; Takashi Murakami

Book ID: 107694044
Publisher: S. Karger AG
Year: 2012
Tongue: English
Weight: 696 KB
Volume: 33
Category: Article
ISSN: 1010-4283
DOI: 10.1007/s13277-011-0300-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effect of Biological Effective Dose

The Effect of Biological Effective Dose on Time to Symptom Progression in Metastatic Renal Cell Carcinoma

✍ D. Wilson; L. Hiller; L. Gray; M. Grainger; A. Stirling; N. James 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 150 KB

A population-based study evaluating the

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer

✍ Daniel Y. C. Heng; Kim N Chi; Nevin Murray; Tao Jin; Jorge A Garcia; Ronald M Bu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Abstract ## BACKGROUND: Sunitinib has replaced interferon (IFN) as a first‐line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. ## METH

Pretreatment assessment of tumor enhance

Pretreatment assessment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy

✍ Kyung Seok Han; Dae Chul Jung; Hyuck Jae Choi; Min Soo Jeong; Kang Su Cho; Jae Y 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

A cost-effectiveness analysis of sunitin

A cost-effectiveness analysis of sunitinib in patients with metastatic renal cell carcinoma intolerant to or experiencing disease progression on immunotherapy: perspective of the Spanish National Health System

✍ L. Paz-Ares; J. G. Del Muro; E. Grande; S. Díaz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

A phase II study of the cancer vaccine T

A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

✍ Stéphane Oudard; Olivier Rixe; Benoit Beuselinck; Claude Linassier; Eugeniu Banu 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 411 KB

Prolonged use of the tyrosine kinase inh

Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis rates

✍ Shruti N. Tapiawala; Joanne M. Bargman; Dimitrios G. Oreopoulos; Martin Simons 📂 Article 📅 2009 🏛 Springer Netherlands 🌐 English ⚖ 137 KB